Morning Wire From Diet to Drugs: Inside HHS’s Push for Bold Reforms
28 snips
Sep 27, 2025 Dr. Marty McCary, FDA Commissioner and a seasoned contributor, delves into groundbreaking discussions on autism research and FDA policy. He shares insights on a new link between acetaminophen during pregnancy and autism risk, shedding light on important study findings. Dr. McCary also highlights innovative treatments involving leucovorin for autistic children and emphasizes his aims for the FDA, including speeding up drug approvals and improving children's nutrition. Additionally, he addresses reforming sunscreen regulations to enhance safety.
AI Snips
Chapters
Transcript
Episode notes
Acetaminophen Linked To Autism Risk
- HHS/FDA flagged acetaminophen in pregnancy as a potential cause linked to autism based on large studies and expert opinion.
- The agency will update labeling and notify physicians to err on the side of safety given the evidence.
Notify Doctors And Reconsider Fevers
- HHS will change labeling and has sent a "dear doctor" letter to inform clinicians about the association.
- Physicians and parents should reconsider routine treatment of low-grade fevers in pregnancy and prioritize caution.
Timing And Duration Matter
- Duration and proximity of acetaminophen use in pregnancy correlate with increased autism risk and acetaminophen appears in cord blood.
- McCary argues existing observational evidence is strong enough to act without waiting for long randomized trials.